These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 2120029

  • 1. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D, Bailly D, Le Seac'h H, Parquet PJ.
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [Abstract] [Full Text] [Related]

  • 2. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E, Liebowitz MR, DeCaria C, Fairbanks J, Fallon B, Klein DF.
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 5. Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment.
    Greist JH.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():44-50; discussion 55-8. PubMed ID: 2116405
    [Abstract] [Full Text] [Related]

  • 6. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 7. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [Abstract] [Full Text] [Related]

  • 8. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
    Trabert W, Hohagen F, Winkelmann G, Berger M.
    Pharmacopsychiatry; 1995 May; 28(3):95-7. PubMed ID: 7568372
    [Abstract] [Full Text] [Related]

  • 9. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluvoxamine in the treatment of panic disorder with obsessive-compulsive symptoms.
    Servant D, Bailly D, Parquet PJ.
    Am J Psychiatry; 1988 Sep; 145(9):1174-5. PubMed ID: 3137830
    [No Abstract] [Full Text] [Related]

  • 12. [The role of drugs in the treatment of obsessive-compulsive disorders].
    den Boer JA, Westenberg HG.
    Ned Tijdschr Geneeskd; 1990 Mar 10; 134(10):503-4. PubMed ID: 2107405
    [No Abstract] [Full Text] [Related]

  • 13. Obsessive-compulsive symptoms in patients with panic disorder.
    Torres AR, Dedomenico AM, Crepaldi AL, Miguel EC.
    Compr Psychiatry; 2004 Mar 10; 45(3):219-24. PubMed ID: 15124153
    [Abstract] [Full Text] [Related]

  • 14. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
    den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS.
    Int Clin Psychopharmacol; 1987 Jan 10; 2(1):21-32. PubMed ID: 3117876
    [Abstract] [Full Text] [Related]

  • 15. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R, McLeod DR, Hipsley PA.
    J Clin Psychopharmacol; 1993 Oct 10; 13(5):321-6. PubMed ID: 8227490
    [Abstract] [Full Text] [Related]

  • 16. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA, Saeed SA, Bruce TJ.
    J Clin Psychiatry; 1996 Oct 10; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [Abstract] [Full Text] [Related]

  • 17. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R.
    Am J Psychiatry; 1987 Dec 10; 144(12):1543-8. PubMed ID: 3120604
    [Abstract] [Full Text] [Related]

  • 18. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M, Robbe-Grillet P, Milliery M, Pham S, Amireche S, Fanget F, Guerin J, Cottraux J.
    Encephale; 2001 Dec 10; 27(3):229-37. PubMed ID: 11488253
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M.
    J Clin Psychiatry; 1982 Dec 10; 43(12):487-91. PubMed ID: 6131065
    [Abstract] [Full Text] [Related]

  • 20. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul 10; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.